….is to reimagine medicine to improve and extend people’s lives. We use innovative science and technology to address some of society’s most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible. We also aim to reward those who invest their money, time and ideas in our company.
Our vision is to become the most valued and trusted medicines company in the world
Novartis is structured to deliver innovative products, exploit global scale, and respond to new opportunities and risks. Our divisions – Innovative Medicines and Sandoz – are supported by functional organizations with global scale.
Made up of two business units – Novartis Pharmaceuticals, which includes Novartis Gene Therapies, and Novartis Oncology – our Innovative Medicines division commercializes innovative patented medicines to enhance health outcomes for patients and healthcare professionals.
Sandoz is a global leader in generic pharmaceuticals and biosimilars that pioneers novel approaches to help people around the world access high-quality medicines.
Advanced Accelerator Applications
Advanced Accelerator Applications is a Novartis company focused exclusively on radioligand therapy and precision imaging.
Novartis was created in 1996 through a merger of Ciba-Geigy and Sandoz. Novartis and its predecessor companies trace roots back more than 250 years, with a rich history of developing innovative products.